- Home
- QRVO vs HALO Comparison
QRVO vs HALO Comparison
Compare QRVO & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QRVO
- HALO
- Stock Information
- Founded
- QRVO 1957
- HALO 1998
- Country
- QRVO United States
- HALO United States
- Employees
- QRVO N/A
- HALO N/A
- Industry
- QRVO Semiconductors
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QRVO Technology
- HALO Health Care
- Exchange
- QRVO Nasdaq
- HALO Nasdaq
- Market Cap
- QRVO 7.1B
- HALO 7.3B
- IPO Year
- QRVO 1997
- HALO N/A
- Fundamental
- Price
- QRVO $76.07
- HALO $57.75
- Analyst Decision
- QRVO Hold
- HALO Buy
- Analyst Count
- QRVO 19
- HALO 9
- Target Price
- QRVO $91.65
- HALO $62.78
- AVG Volume (30 Days)
- QRVO 2.6M
- HALO 1.1M
- Earning Date
- QRVO 01-28-2025
- HALO 02-18-2025
- Dividend Yield
- QRVO N/A
- HALO N/A
- EPS Growth
- QRVO N/A
- HALO 63.33
- EPS
- QRVO 0.28
- HALO 3.43
- Revenue
- QRVO $3,790,485,000.00
- HALO $1,015,324,000.00
- Revenue This Year
- QRVO $0.09
- HALO $23.48
- Revenue Next Year
- QRVO N/A
- HALO $18.16
- P/E Ratio
- QRVO $269.04
- HALO $16.84
- Revenue Growth
- QRVO 9.51
- HALO 22.44
- 52 Week Low
- QRVO $64.54
- HALO $37.73
- 52 Week High
- QRVO $130.99
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- QRVO 43.10
- HALO 62.93
- Support Level
- QRVO $76.04
- HALO $56.07
- Resistance Level
- QRVO $80.17
- HALO $60.67
- Average True Range (ATR)
- QRVO 2.43
- HALO 1.43
- MACD
- QRVO -0.73
- HALO -0.22
- Stochastic Oscillator
- QRVO 9.69
- HALO 48.86
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.